Ameritas Investment Partners’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.7K Hold
1,679
﹤0.01% 2458
2025
Q4
$44.1K Sell
1,679
-355
-17% -$9.21K ﹤0.01% 2217
2025
Q3
$46K Hold
2,034
﹤0.01% 2194
2025
Q2
$40.4K Hold
2,034
﹤0.01% 2322
2025
Q1
$34.4K Hold
2,034
﹤0.01% 2309
2024
Q4
$37.6K Hold
2,034
﹤0.01% 2348
2024
Q3
$44.2K Hold
2,034
﹤0.01% 2267
2024
Q2
$39.9K Hold
2,034
﹤0.01% 2264
2024
Q1
$44.1K Hold
2,034
﹤0.01% 2223
2023
Q4
$58.8K Hold
2,034
﹤0.01% 2072
2023
Q3
$54.4K Buy
2,034
+443
+28% +$15.1K ﹤0.01% 2054
2023
Q2
$58.9K Hold
1,591
﹤0.01% 1944
2023
Q1
$49.7K Hold
1,591
﹤0.01% 1991
2022
Q4
$54K Hold
1,591
﹤0.01% 2006
2022
Q3
$60K Hold
1,591
﹤0.01% 1846
2022
Q2
$86K Hold
1,591
﹤0.01% 1614
2022
Q1
$99K Hold
1,591
﹤0.01% 1659
2021
Q4
$160K Hold
1,591
0.01% 1379
2021
Q3
$143K Hold
1,591
0.01% 1463
2021
Q2
$147K Buy
1,591
+456
+40% +$36.4K 0.01% 1478
2021
Q1
$110K Hold
1,135
﹤0.01% 1609
2020
Q4
$59K Buy
1,135
+281
+33% +$11.7K ﹤0.01% 1883
2020
Q3
$34K Hold
854
﹤0.01% 2072
2020
Q2
$14K Buy
+854
New +$13.1K ﹤0.01% 2536
2017
Q2
Sell
-310
Closed -$3K 3010
2017
Q1
$3K Buy
+310
New +$3.67K ﹤0.01% 2898

Other funds holding FLGT

Ameritas Investment Partners's FLGT Position: Q1 2026 in Review

Ameritas Investment Partners held its Fulgent Genetics (FLGT) position steady in Q1 2026 at 1,679 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Ameritas Investment Partners first reported a position in FLGT in Q1 2017 and has held it in 25 quarters since. The position peaked at $160K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Ameritas Investment Partners held 1,679 shares of Fulgent Genetics worth $26.7K as of Q1 2026.
  • Ameritas Investment Partners left its Fulgent Genetics share count unchanged in Q1 2026.
  • Fulgent Genetics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2458 holding.
  • Ameritas Investment Partners first reported a position in Fulgent Genetics in Q1 2017 and has held it in 25 quarters since.
  • Ameritas Investment Partners's Fulgent Genetics position peaked at $160K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.